• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Impax Laboratories Inc

+ Add to Watchlist


38.2400 USD 1.3700 3.72%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Impax Laboratories Inc (IPXL)

Open: 36.7500 Day's Range: 36.5400 - 38.2700 Volume: 591,420
Previous Close: 36.8700 52wk Range: 21.3400 - 38.2700 1-Yr Rtn: +59.40%

Stock Chart for IPXL

No chart data available.
  • IPXL:US 38.2400
  • 1D
  • 1M
  • 1Y
Interactive IPXL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IPXL

Current P/E Ratio (ttm) 39.5265
Estimated P/E(12/2014) 29.9922
Relative P/E vs. SPX 2.1701
Earnings Per Share (USD) (ttm) 0.9675
Est. EPS (USD) (12/2014) 1.2750
Est. PEG Ratio 1.0858
Market Cap (M USD) 2,724.54
Shares Outstanding (M) 71.25
30 Day Average Volume 765,743
Price/Book (mrq) 3.0445
Price/Sale (ttm) 4.5928
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/20/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IPXL

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IPXL

Impax Laboratories, Inc. develops, manufactures, and markets both proprietary and multi-source pharmaceutical products utilizing its drug delivery technologies. The Company specializes in the development of niche and controlled release generics, as well as the development of branded products.

George Frederick Wilkinson "Fred"President/CEOMichael J NestorPres:Impax Pharmaceuticals
Bryan M ReasonsSenior VP:Finance/CFOMark A SchlossbergSenior VP/Secy/General Counsel
More Company Profile & Key Executives for IPXL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil